Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Revance to Participate in the William Blair 42nd Annual Growth Stock Conference


Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the William Blair 42nd Annual Growth Stock Conference, taking place June 6-9, in Chicago. Chief Executive Officer, Mark Foley, is scheduled to present on Monday, June 6, at 2:00 p.m. CT / 3:00 p.m. ET.

Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company's website at www.revance.com. The webcast replay will be available after the conclusion of the live presentation for 90 days.

About Revance Therapeutics, Inc.

Revance is a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation, long-acting neuromodulator product, DaxibotulinumtoxinA for Injection. Revance has successfully completed Phase 3 clinical programs for DaxibotulinumtoxinA for Injection in glabellar (frown) lines, for which the company is currently pursuing U.S. regulatory approval, and in cervical dystonia. Revance is also evaluating DaxibotulinumtoxinA for Injection in adult upper limb spasticity. Revance owns a unique portfolio of premium products and services for U.S. aesthetics practices, including the exclusive U.S. distribution rights to the RHA® Collection of dermal fillers, the first and only range of FDA-approved fillers for correction of dynamic facial wrinkles and folds, and the OPULtm Relational Commerce Platform. Revance has also partnered with Viatris (formerly Mylan N.V.) to develop a biosimilar to BOTOX®, which if approved, would be the first and only generic biosimilar to Botox® and Botox® Cosmetic. For more information or to join our team visit us at www.revance.com.

"Revance Therapeutics" and the Revance logo are registered trademarks of Revance Therapeutics, Inc.

Resilient Hyaluronic Acid® and RHA® are trademarks of TEOXANE SA.

BOTOX® is a registered trademark of Allergan, Inc.


These press releases may also interest you

at 10:10
ISG to Publish Reports on Contact Center Customer Experience Services
Information Services Group (ISG) , a leading global technology research and advisory firm, has launched a research study examining providers of contact center customer experience services that address rapidly changing work models and a growing...

at 10:01
Robotic Palletizer Market worth $1.9 billion by 2029 - Exclusive Report by MarketsandMarketstm
The robotic palletizer market is projected to grow from USD 1.4 billion in 2024 and is expected to reach USD 1.9 billion by 2029, growing at a CAGR of 5.9% from 2024 to 2029 according to a new report by MarketsandMarketstm. Rising awareness towards...

at 10:00
Zefiro Methane Founder and CEO Talal Debs Interviewed on the Smarter Markets Podcast
ZEFIRO METHANE CORP. (the "Company", "Zefiro", or "ZEFI") is pleased to announce that its Founder and CEO Talal Debs PhD was recently interviewed on the Smarter Markets podcast. In this episode, Dr. Debs discussed the global methane emissions crisis,...

at 10:00
iClone BuildingGen Ushers Intuitive Procedural 3D Building Creation
Gone are the painstaking days of piecemeal 3D building assembly. The iClone BuildingGen plugin empowers architects, professional designers, and hobbyists alike to effortlessly create diverse 3D buildings using procedural Blueprints. This plugin...

at 10:00
HGTV SMART HOME GIVEAWAY 2024 IN ATLANTA, GEORGIA, NOW OPEN FOR ENTRIES
Beginning at 9 a.m. ET today, April 19, 2024, through 5 p.m. ET on June 10, 2024, fans can enter for their chance to win the HGTV® Smart Home 2024 located in Atlanta, Georgia. The prize package, valued at over $1 million, includes a newly renovated,...

at 09:55
Viz.ai Wins 2024 Edison Awardtm for Innovation for Second Year in a Row
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has been named an Edison Award Winner in the 2024 Edison Awards, for the second year in a row. Viz PE with right ventricle/left ventricle...

More news about Science and technology...


News published on and distributed by: